Abbonarsi

Characterizing respiratory syncytial virus (RSV) infections before and during the COVID-19 pandemic - 12/12/24

Doi : 10.1016/j.ajem.2024.11.002 
Saamia I. Masoom, MD a, , Gina Aloisio, MD PhD a , Elizabeth A. Camp, PhD a , James J. Dunn, PhD b , Sarah D. Meskill, MD MS a
a Division of Pediatric Emergency Medicine, Department of Pediatrics, Baylor College of Medicine, 6621 Fannin St., Suite A210, Houston, TX 77030, United States of America 
b Department of Pathology & Immunology, Baylor College of Medicine, One Baylor Plaza, BCM 315, Houston, TX 77030, United States of America 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Following the onset of the COVID-19 pandemic, RSV infections deviated from a previously reliable epidemiologic pattern of presentation. To investigate whether this change in RSV seasonality resulted in a change in frequency and severity of RSV infections, this single center retrospective study compares demographic and hospital factors during RSV seasons before and after the onset of the COVID-19 pandemic.

Methods

Included were patients under age 5 years who tested positive for RSV only by RT-PCR in our pediatric emergency departments during the last three RSV seasons before the onset of the COVID-19 pandemic in spring 2020, as compared to the first three seasons after the pandemic started. RSV seasonality was defined as periods in which greater than 10 % of all RSV RT-PCR tests sent resulted positive. Patients with tracheostomies were excluded, as were duplicate tests performed in the same patient within 1 day. Demographic data obtained included patient age, sex, and weight. Hospital factors obtained were inpatient admission and length of stay (LOS), intensive care unit (ICU) admission and LOS, respiratory support during the encounter, and mortality. A planned subgroup analysis isolating the first RSV season after the pandemic's onset was performed. Mann-Whitney and Pearson Chi-Square testing were used for comparison of continuous and categorical variables, respectively. Significance was set at p < 0.05.

Results

RSV seasons were identified with 7592 cases meeting study criteria (2770 cases before the pandemic's onset and 4822 cases after). While there were more RSV cases identified per season after the onset of COVID-19, testing also increased in this period. RSV positive patients in seasons after the onset of COVID-19 were significantly older than those in seasons before (0.83 years vs. 0.56 years, p < 0.001). They were admitted to the hospital significantly less (46.8 % vs. 54.9 %, p < 0.001), though ICU admission rates did not change significantly (32.9 % vs. 31.1 %, p = 0.25). Both inpatient LOS (64 h vs. 60 h, p = 0.01) and ICU LOS (68 h vs. 88.5 h, p < 0.001) decreased significantly. RSV positive inpatients in seasons after the onset of COVID-19 were significantly more likely to require respiratory support (89.0 % vs. 86.5 %, p = 0.02), with more requiring BIPAP (11.3 % vs. 8.1 %, p = 0.003) and fewer requiring intubation (9.6 % vs. 13.8 %, p < 0.001).

Conclusions

During the first three RSV seasons after the onset of the COVID-19 pandemic, our pediatric emergency departments saw more RSV positive patients than in the last three seasons beforehand. These patients were significantly older and less likely to be admitted, which may be partly due to increased respiratory viral testing during the pandemic. However, shorter LOS and decreased intubations despite increased respiratory support among admitted patients may indicate a paradigm shift in emergency department and inpatient management of severe RSV infections, perhaps encouraged by practice changes and resource limitations due to COVID-19. This information may better guide institutions in predicting resource needs after large-scale infectious disease outbreaks in the future.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

The COVID-19 pandemic elicited changes to the presentation of RSV in the ED.
RSV patients were older, admitted less, had shorter LOS, and used more BIPAP.
Increased age supports the theory of an ‘immunity gap’ following pandemics.
Admission and respiratory data suggest a paradigm shift in RSV management.
This data may help institutions plan for resources needed after future pandemics.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Respiratory syncytial virus, COVID-19, Epidemiology, Pandemic, Pediatrics, Hospitalization


Mappa


© 2024  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 87

P. 108-112 - gennaio 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Signs of life as a favorable predictor for non-shockable cardiac arrest undergoing extracorporeal cardiopulmonary resuscitation post non-shockable cardiac arrest
  • Naofumi Bunya, Hirofumi Ohnishi, Takehiko Kasai, Ryo Nishikawa, Keigo Sawamoto, Shuji Uemura, Narimatsu Eichi
| Articolo seguente Articolo seguente
  • Prognostic value of gray–white matter ratio measured by brain MRI-based CT structures in comatose patients after cardiac arrest
  • Sung Jin Bae, Yoon Hee Choi, Seok Jin Ryu, Dong Hun Lee, Yunhyung Choi, Minsoo Chun, Youngwoo Kim, Dong Hoon Lee

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.